Return to article

Коррекция сдвига пула желчных кислот у вьюнов с экспериментальными гепатопатиями сульфолитохолевой кислотой

Bile acid pool of loach blood serum after 35 days of pharmacocorrection

µmol/L, M ± SD; * — p < 0.05 compared with the control; # — p < 0.05 compared with the corresponding untreated group

Group

TBA

CA

CDCA

DCA

CA/CDCA

Control

5.1 ± 0.9

2.6 ± 0.4

1.7 ± 0.3

0.5 ± 0.1

1.53

HS (without correction)

13.7 ± 1.8*

4.5 ± 0.7*

5.9 ± 0.9*

2.9 ± 0.6*

0.76*

HS+SLCA-200

9.2 ± 1.2*#

3.6 ± 0.5*#

3.8 ± 0.6*#

1.5 ± 0.4*#

0.95#

HS+SLCA-400

7.4 ± 1.0#

3.3 ± 0.5#

2.9 ± 0.5#

1.0 ± 0.3#

1.14#

TH (without correction)

20.6 ± 2.4*

5.6 ± 0.8*

9.4 ± 1.2*

5.1 ± 0.9*

0.60*

TH+SLCA-200

12.4 ± 1.6*#

4.4 ± 0.6*#

5.1 ± 0.8*#

2.2 ± 0.5*#

0.86#

TH+SLCA-400

9.8 ± 1.3#

4.0 ± 0.6#

3.9 ± 0.6#

1.6 ± 0.4#

1.03#